Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROZANOLIXIZUMAB vs ROZANOLIXIZUMAB-NOLI: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROZANOLIXIZUMAB vs ROZANOLIXIZUMAB-NOLI: Safety Overview

Metric ROZANOLIXIZUMAB ROZANOLIXIZUMAB-NOLI
Total FAERS Reports 303 349
Deaths Reported 9 4
Death Rate 3.0% 1.1%
Hospitalizations 114 84
Average Patient Age 61.3 yrs 55.1 yrs
% Female Patients 60.9% 63.3%
Manufacturer UCB, Inc. N/A
Route SUBCUTANEOUS N/A
Marketing Status N/A Prescription